Haemonetics (HAE) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.02 --0%
EPS Growth %: -0.9%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: -0.9%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q1 EPS of $0.36, $0.04 better than the analyst estimate of $0.32. Revenue for the quarter came in at $213.4 million versus the consensus estimate of $215.62 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- JPMorgan Starts Zensho Holdings (7550:JP) at Overweight
- Goldman Sachs Reiterates Conviction Buy Rating on Golar LNG Ltd. (GLNG)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
